Neos Therapeutics Inc. (NEOS) shares are trading at higher $0.53 and the avg recommendation for the stock is Moderate Buy.
To add more color to this target, the company’s high over the last year is $1.98 and the low is $0.45. Over the last 52 weeks, NEOS is down -62.01% while the S&P 500 is up 14.78%. The catalyst for this interesting swing was the company’s recent earnings report.
A Notable Earnings Report
In the last quarter, NEOS reported a profit of $7.25 million. Neos Therapeutics Inc. also saw revenues increase to $13.13 million. In addition, NEOS has free cash flow of -$5.79 million as of 06-2020. The company’s EBITDA came in at -$1.32 million which compares well with its peers.
NEOS booked profit margins of -30.60%, its Return on Equity (ROE) is 197.30%, and its Return on Assets is -22.70%. All told, it is clear that, NEOS needs to be on your watchlist.
Find out when NEOS reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. NEOS has a short ratio of 10.48 and outstanding shares of 49.75M.
NEOS has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 0.35 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at -0.38. Neos Therapeutics Inc. NEOS also noted assets of $62.69 million at the end of the last quarter. Investors should also keep an eye on sector updates as NEOS has historically followed its peers on positive news.
All told, Neos Therapeutics Inc. NEOS has strung together solid data and demonstrated underlying fundamentals. At its current valuation, NEOS represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.
Neos Therapeutics Inc. NEOS is now commanding a market cap of 26.74M and a float of 49.01M. NEOS is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of NEOS stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in NEOS, either long or short, and we have not been compensated for this article.